Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

28.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 145.00p
  • 52 Week Low: 10.25p
  • Currency: UK Pounds
  • Shares Issued: 147.54m
  • Volume: 1,242,620
  • Market Cap: £41.31m
  • RiskGrade: 348
  • Beta: 0.11

ShareCast News

Renalytix appoints Ann Berman to board 28-Jul-2021 ShareCast
Renalytix upbeat on new KidneyIntelX data 28-Jun-2021 ShareCast
Director dealings: Renalytix AI interim chairman... 22-Jun-2021 ShareCast
Net losses balloon at Renalytix AI in third quar... 15-Jun-2021 ShareCast
Renalytix AI upbeat on results of utility study 03-Jun-2021 ShareCast
Renalytix AI enters new partnership in America's... 19-May-2021 ShareCast
Renalytix AI wins 10-year US government contract 22-Apr-2021 ShareCast
Renalytix AI upbeat on new study findings 20-Apr-2021 ShareCast
Renalytix AI enters option agreement with Joslin... 14-Apr-2021 ShareCast
Renalytix AI upbeat on KidneyIntelX study results 08-Apr-2021 ShareCast
Renalytix AI upbeat on latest 'KidneyIntelX' stu... 06-Apr-2021 ShareCast
Renalytix AI confident despite delay to new US M... 15-Mar-2021 ShareCast
Renalytix AI losses widen as it progresses devel... 02-Mar-2021 ShareCast
Renalytix AI enters partnership with Univeristy ... 24-Feb-2021 ShareCast
Sunday share tips: N Brown, Foxtons 17-Jan-2021 ShareCast
Renalytix AI enters chronic kidney disease partn... 05-Jan-2021 ShareCast
Renalytix AI commercially launches KidneyIntelX 18-Sep-2020 ShareCast
Renalytix to work on chronic disease strategies ... 21-Aug-2020 ShareCast
Renalytix AI gets clinical laboratory permit in ... 12-Jun-2020 ShareCast
Renalytix AI upbeat on latest 'KidneyIntelX' res... 10-Jun-2020 ShareCast
US national pricing comes into effect for Renaly... 03-Jan-2020 ShareCast
Renalytix AI gets national Medicare pricing for ... 03-Dec-2019 ShareCast
Renalytix AI gets preliminary Medicare pricing f... 30-Sep-2019 ShareCast
Renalytix AI expands 'KidneyIntelX' investigator... 06-Aug-2019 ShareCast
Renalytix AI appoints Thomas McLain as chief com... 29-Jul-2019 ShareCast
Renalytix AI prepares for US roll-out with CPT c... 01-Jul-2019 ShareCast
Sunday share tips: CYBG, Renalytix AI 16-Jun-2019 ShareCast
Renalytix AI begins clinical validation study fo... 23-Jan-2019 ShareCast
Renalytix AI exercises option to license Fractal... 02-Jan-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 28.00p
Change Today 4.00p
% Change 16.67 %
52 Week High 145.00p
52 Week Low 10.25p
Volume 1,242,620
Shares Issued 147.54m
Market Cap £41.31m
Beta 0.11
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.72% below the market average23.72% below the market average23.72% below the market average23.72% below the market average23.72% below the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average
Price Trend
90.21% below the market average90.21% below the market average90.21% below the market average90.21% below the market average90.21% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
19.97% above the market average19.97% above the market average19.97% above the market average19.97% above the market average19.97% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

RENX Dividends

No dividends found

Trades for 02-May-2024

Time Volume / Share Price
17:07 276,639 @ 28.00p
16:29 3,603 @ 29.00p
16:28 32,333 @ 28.75p
16:23 25,000 @ 26.75p
15:21 50,000 @ 26.70p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page